Fluxome Sciences AS
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fluxome Sciences AS
Roche paying $450 million for Danish biotech Santaris is likely to fuel excitement around RNA-targeting technologies and may generate a liquidity boost for Europe’s VC sector.
Kidman joins Swisse as brand goes global; Rubin moves to Ropes & Gray; MHRA names chairman, non-executive directors; Green Bay Packer on Old Spice team; Michaels promotes Eboost; more People In Brief.
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.